MYO18B and hepatocellular carcinoma: In this report, we found that the phosphorylation levels of PI3K, Akt and mTOR were significantly suppressed by MYO18B knockdown in HepG2 cells, suggesting that MYO18B knockdown could inhibit the activation of PI3K/AKT/mTOR signaling pathway in HCC.